Stanford Chemist, Seeking Alpha

Stanford Chemist

Seeking Alpha

Contact Stanford

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Seeking Alpha

Recent articles by Stanford:

Weekly Closed-End Fund Roundup: Aug 7, 2022

19 out of 23 CEF sectors positive on price and 17 out of 23 sectors positive on NAV last week. SMM will pay a Saba special distribution, funded by management. → Read More

The 'High-High-Low' Closed-End Fund Report, July 2022

Only funds with yields over 6.5%, coverage higher than 85% and trading at under a +5% premium are considered. Top lists of discount, yield, DxY and DxYxZ are given. → Read More

Weekly Closed-End Fund Roundup: VFL Tender Offer (July 24, 2022)

21 out of 23 CEF sectors positive on price and 22 out of 23 sectors positive on NAV last week. Saba scores a victory against VFL. Click here to read. → Read More

The Chemist's Quality Closed-End Fund Report, July 2022

Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. → Read More

Weekly Closed-End Fund Roundup: July 17, 2022

Weekly Closed-End Fund Roundup: July 17, 2022: 21 out of 23 CEF sectors positive on price and 16 out of 23 sectors positive on NAV last week. Read more here. → Read More

GLU: Rights Offering Unexpectedly Decent (NYSE:GLU)

GLU's rights offering has concluded. A higher than expected number of rights holders subscribed. Subscribers obtained only a thin discount to the subscription price. → Read More

SMM: Discount Elimination With Proposed Merger

The board of SMM has proposed a merger with an open-ended fund which would eliminate the discount. Read more for a possible arbitrage strategy. → Read More

Weekly Closed-End Fund Roundup: July 17, 2022

21 out of 23 CEF sectors were positive on price and 16 out of 23 sectors were positive on NAV last week. Saba moves against SMM. → Read More

CLM And CRF Rights Offerings: A Success For Managers And Oversubscribers Alike

CLM and CRF's rights offerings were oversubscribed. The rights offerings were a success for managers and oversubscribers alike. Click to read more... → Read More

The 'High-High-Low' Closed-End Fund Report, June 2022

The High-High-Low CEF report screens for three attributes; High distributions, High coverage and Low premium/discount value. Check out June 2022 report here. → Read More

Weekly Closed-End Fund Roundup: June 19, 2022

0 out of 23 CEF sectors positive on price and 0 out of 23 sectors positive on NAV last week. Commodities lead while MLPs lag. → Read More

Weekly Closed-End Fund Roundup: June 5, 2022

7 out of 23 CEF sectors positive on price and 11 out of 23 sectors positive on NAV last week. CLM/CRF rights offerings expiring this week. Read more here. → Read More

The 'High-High-Low' Closed-End Fund Report, May 2022

The High-High-Low report screens for high distributions, high coverage and low premium/discount value. Click here to know more. → Read More

HIX: Rights Offering Recap And Future Prospects (NYSE:HIX)

HIX's rights offering has concluded. The subscription floor prevented more severe dilution. Read more about HIX's rights offering and future prospects. → Read More

GLU CEF: Rights Offering Quick Notes (NYSE:GLU)

GLU's rights offering is now live. Rights are discounted versus their intrinsic value, possibly arbitrage opportunity. Do not subscribe if GLU drops below $16 at expiry. → Read More

The Quality Closed-End Fund Report, May 2022

Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. Top DxYxZ funds are HFRO, EHI, and IVH. → Read More

Weekly Closed-End Fund Roundup: GUT Rights Offering Results (April 24, 2022) (NYSE:GUT)

1 out of 22 CEF sectors positive on price and 1 out of 22 sectors positive on NAV last week. GUT has completed its rights offering, which was oversubscribed. → Read More

The 'High-High-Low' Closed-End Fund Report, April 2022

In this article, closed end funds with yields over 6.5%, coverage higher than 85%, and trading at under a +5% premium are considered. Check out the lists. → Read More

NHS: Rights Offering Quick Notes (NYSE:NHS)

NHS's rights offering is now live. The subscription formula has a floor of a -13% discount. Sidestepping the rights offering seems to have been the correct play once again. → Read More

Quick Notes On HIX Rights Offering (NYSE:HIX)

HIX rights offering is not going well for managers, but that's a positive for shareholders. Read what shareholders should know about HIX here. → Read More